longda(SH:688231) Zheng Quan Zhi Xing·2025-06-13 10:41Core Viewpoint - The company has adjusted the grant price of the 2023 restricted stock incentive plan and has invalidated a portion of the granted but unvested restricted stocks due to various reasons, including employee departures and voluntary waivers [1][4][7]. Approval Procedures - The company held multiple board and supervisory meetings to review and approve the 2023 restricted stock incentive plan, including its draft and management methods [2][3][5]. - Independent directors provided their consent on the relevant proposals during these meetings [2][5]. Adjustment Details - The grant price of the restricted stock was adjusted from 12.08 yuan per share to 11.72 yuan per share, following the company's profit distribution practices [6][7]. - The adjustment formula used was P = P0 - V, where P0 is the original grant price and V is the dividend per share [6][7]. Invalidated Restricted Stocks - A total of 959,200 shares of restricted stock were invalidated due to the departure of 9 incentive targets and the voluntary waiver by another 9 targets [7][8]. - The invalidation of these shares is in accordance with the company's incentive plan and relevant regulations [7][9]. Impact on the Company - The adjustments to the grant price and the invalidation of restricted stocks are not expected to have a material impact on the company's financial status or operational results [7][8]. - The stability of the management team and the continuation of the stock incentive plan will not be affected by these changes [7][8]. Independent Opinions - Independent directors and legal advisors have confirmed that the adjustments and invalidations comply with relevant laws and regulations, and do not harm the interests of the company or its shareholders [8][9].